(HealthDay News) — Mutations in PALB2 and germline mutations in the multiple endocrine neoplasia type 1 (MEN1) tumor-suppressor gene causing MEN1 correlate with increased breast cancer risk  according to two studies published in the August 7 issue of the New England Journal of Medicine